Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMBS > SEC Filings for AMBS > Form 8-K on 11-Feb-2013All Recent SEC Filings

Show all filings for AMARANTUS BIOSCIENCE, INC.

Form 8-K for AMARANTUS BIOSCIENCE, INC.


11-Feb-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events

On 8 February 2013, the Board of Directors of Amarantus Bioscience, Inc. finding that it would be beneficial for the Company to form a subsidiary and license the Company's diagnostic Intellectual Property to the subsidiary, approved a Resolution directing Amarantus' officers to take any all steps necessary dto form the subsidiary and license the Company's diagnostic IP to it, including the LymPro Alzheimer's disease blood test, and the NuroPro Diagnostic Platform, including the NuroPro Parkinson's disease blood test.

The name of the new diagnostic subsidiary will be Amarantus Diagnostics, Inc. The Company's current President and CEO, Gerald Commissiong, will be the initial sole Director and interim CEO of the diagnostics subsidiary and the Company's CFO, Marc Faeber, will be the interim CFO. Amarantus Diagnostics, Inc's lead asset will be the LymPro Alzheimer's disease blood test.

A copy of the Unanimous Consent of the Board of Directors adopting the resolution to form Amarantus Diagnostics, Inc. is attached as Exhibit 99.1 to this Form.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.

99.1 Unanimous Consent of the Board of Directos of Amarantus Bioscience, Inc. adopting the resolution to form a subsidiary: Amarantus Diagnostics, Inc.

  Add AMBS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMBS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.